Stockreport

Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results

Enveric Biosciences, Inc.  (ENVB) 
PDF Advanced pre-IND activities and research for lead candidate, EB-003, a novel neuroplastogenic molecule designed to treat severe mental health disordersAnnounced the expa [Read more]